1-3 of 3
Kevin K Dobbin, PhD
Close
Sort by
Journal Articles

Identification of Novel Cluster Groups in High-Risk Pediatric B-Precursor Acute Lymphoblastic Leukemia (HR-ALL) by Gene Expression Profiling: Correlation with Clinical and Outcome Variables. a Children’s Oncology Group (COG) Study.

Richard C. Harvey, PhD, I-Ming Chen, MS, Kerem Ar, MS, Stephen P. Hunger, MD, Mignon Loh, MD, Eric C. Larsen, MD, Meenakshi Devidas, PhD, Elizabeth Raetz, MD, Gregory Reaman, MD, William L. Carroll, MD, Naomi Winick, MD, Malcolm Smith, MD, PhD, Kevin K Dobbin, PhD, Cheryl L. Willman, MD
Journal: Blood
Blood (2008) 112 (11): 2256.
https://doi.org/10.1182/blood.V112.11.2256.2256
Published: 2008
Journal Articles

Use of Genomic Technologies to Identify Novel Genetic Abnormalities and Therapeutic Targets In Acute Lymphoblastic Leukemia.

Cheryl L. Willman, MD, Huining Kang, PhD, Richard C. Harvey, PhD, I-Ming Chen, DVM, MS, Charles Mullighan, MD, James R. Downing, MD, Mary V. Relling, PharmD, Jinghui Zhang, PhD, Daniela Gerhard, PhD, Malcolm Smith, MD, PhD, Kevin K. Dobbin, PhD, Gregory Reaman, MD, Stephen Hunger, MD
Journal: Blood
Blood (2008) 112 (11): sci-8.
https://doi.org/10.1182/blood.V112.11.sci-8.sci-8
Published: 2008
Journal Articles

Expression Profiling Identifies Novel Genetic Subgroups with Distinct Clinical Features and Outcome in High-Risk Pediatric Precursor B Acute Lymphoblastic Leukemia (B-ALL). A Children’s Oncology Group Study.

Richard C. Harvey, PhD, George S. Davidson, Xuefei Wang, PhD, Kevin K. Dobbin, PhD, Edward J. Bedrick, PhD, Carla S. Wilson, MD, PhD, Susan R. Atlas, PhD, Huining Kang, PhD, I-Ming Chen, DVM, Stephen P. Hunger, MD, Meenakshi Devidas, PhD, William L. Carroll, MD, Paul Bowman, MD, Bruce Camitta, MD, Gregory Reaman, MD, Cheryl L. Willman, MD
Journal: Blood
Blood (2007) 110 (11): 1430.
https://doi.org/10.1182/blood.V110.11.1430.1430
Published: 2007